Biocompatibles International plc
("Biocompatibles" or the "Company")
Directors' Share Dealing
Farnham, UK, 15 January 2010: Biocompatibles International plc (LSE: BII)
announces the following transactions in relation to its directors and its
employee share schemes.
Awards made on 29 December 2006 under the Biocompatibles International
Performance Share Plan vested in full on 29 December 2009. The awards are nil
cost options with an exercise period of 6 months following vesting.
The Company received notification on 14 January 2010 that the following
directors exercised these nil cost options in full and sold shares to the
Biocompatibles International Employee Benefit Trust (the "Trust") on 12 January
2010. The shares were sold at a price of 238.755 pence per share to fund or
part fund the directors' income tax and national insurance liabilities arising
upon receipt of the vested shares. The sale price was determined by taking the
middle of the high and low prices on 11 January 2010. The Company also received
notification on 14 January 2010 that John Sylvester sold shares on the London
Stock Exchange on 14 January at a price of 235 pence per share. This sale was
to consolidate his shareholding and also part fund his tax liabilities arising
upon receipt of the vested shares.
Director Number of Shares sold on 12 Number of shares Resulting
options January 2010 at sold on 14 January total
vested and 238.755p each to 2010 at 235p each shareholding
exercised fund or part fund to fund or part
income tax and fund income tax
national insurance and national
liabilities insurance
liabilities
Crispin Simon 35,000 17,038 Nil 270,380
Ian Ardill 35,000 10,000 Nil 71,479
Peter 35,000 17,038 Nil 30,602
Stratford
John Sylvester 35,000 11,038 5,000 30,271
On 12 January 2010, the Trust had purchased 20,000 Biocompatibles shares,
following a recommendation from the Company, to satisfy vesting of the awards
referred to above and also employee share awards vesting on 2 January 2010.
This purchase was made on the London Stock Exchange at 245 pence per share.
Following the awards and transactions referred to above, the Trust held 8,501
Biocompatibles shares.
This announcement is given in accordance with the Company's obligations under
Disclosure Rule 3.1.4R.
- Ends -
Biocompatibles Tel: +44 (0)1252 732706
Ian Ardill, Finance Director
Sari Evetts, Assistant Company Secretary